From: Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
Shortest Time to Event (after initiation of treatment) | Longest Time to Event (after initiation of treatment) |
---|---|
Uveitis | |
 2 weeks | 2 years |
Neuro-ophthalmic disorders | |
 1 week | 5 years |
Orbit and ocular adnexa | |
 10 days | 8 months |
Retina | |
 5 days | 2 months |
Cornea and ocular surface | |
 1 week | 18 months |